This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ballantyne, C. M. Articles by Entman, M. L. Search for Related Content PubMed PubMed Citation Articles by Ballantyne, C. M. Articles by Entman, M. L. Related Collections Other Vascular biology

(Circulation. 2002;106:766.)
© 2002 American Heart Association, Inc.

Editorial

Soluble Adhesion Molecules and the Search for Biomarkers for Atherosclerosis

Christie M. Ballantyne, MD; Mark L. Entman, MD

From the Section of Atherosclerosis and Lipoprotein Research (C.M.B.) and the Section of Cardiovascular Sciences (M.L.E.), Department of Medicine, Baylor College of Medicine, Methodist DeBakey Heart Center, Houston, Tex.

Correspondence to Christie M. Ballantyne, MD, Baylor College of Medicine, 6565 Fannin, MS A-601, Houston, TX 77030. E-mail cmb@ bcm.tmc.edu

Key Words: Editorials • cell adhesion molecules • risk factors • tests • atherosclerosis

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Advances in the understanding of the molecular basis of inflammation, atherogenesis, and plaque instability have led to the identification of a number of molecules that are posited to play a critical role in various aspects of atherosclerotic lesions and/or their lability, which can be measured quantitatively in plasma. Intercellular cell adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) are two important members of the immunoglobulin gene superfamily that play important but different roles in the adhesion of leukocytes to the vascular endothelium. VCAM-1, which is the endothelial ligand for ₄ß ₁ (very late antigen 4 [VLA-4]), has been postulated to play the more critical role in monocyte adherence to endothelial cells under flow conditions. ICAM-1 ligands include CD11a/CD18 (LFA-1) and CD11b/CD18 (Mac-1), which are present on monocytes, lymphocytes, and neutrophils. Increased expression of ICAM-1 and VCAM-1 is observed in atherosclerotic lesions, and mice deficient in either ICAM-1 or VCAM-1 have reduced response to experimental atherosclerotic stimuli (eg, apolipoprotein E deletion). In the mouse, a deficiency of VCAM-1 seems to play a more important role in the initiation of atherosclerosis than does a deficiency of ICAM-1.¹ Although membrane-bound forms of either adhesion molecule are difficult to measure in vivo, soluble forms can be detected in the serum or plasma and are increased in many conditions with an inflammatory component.² The levels of soluble ICAM-1 (sICAM-1) in apolipoprotein E-deficient mice increases over time in parallel with the progression of atherosclerosis, providing evidence in a murine model that sICAM-1 may correlate . . . [Full Text of this Article]

This article has been cited by other articles:

				J. Li, Y. Doerffel, B. Hocher, and T. Unger Inflammation in the genesis of hypertension and its complications the role of angiotensin II Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3107 - 3109. [Full Text] [PDF]

				M S O'Neill, A Veves, J A Sarnat, A Zanobetti, D R Gold, P A Economides, E S Horton, and J Schwartz Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility Occup. Environ. Med., June 1, 2007; 64(6): 373 - 379. [Abstract] [Full Text] [PDF]

				R. V. Perez, C. Q. Huang, J. R. Johnson, B. J. Gallay, M. M. Gandhi, J. P. McVicar, and C. Troppmann Pretransplantation Soluble Adhesion Molecule Expression Predicts Outcome After Living Donor Renal Transplantation Arch Surg, October 1, 2003; 138(10): 1113 - 1120. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin and R. M. Touyz Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade J. Am. Coll. Cardiol., September 3, 2003; 42(5): 911 - 913. [Full Text] [PDF]

				A. Kretowski, I. Kinalska, K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, D. Giugliano, L. Quagliaro, et al. Serum Levels of Interleukin-18--a Potential Marker of Cardiovascular Death--Could Be Determined by Genetic Predisposition * Response Circulation, June 10, 2003; 107 (22): e206 - e207. [Full Text] [PDF]